BAY-549
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-10319-5MG | 5 mg | 456,00 | Add | |
| HY-10319-1ML | 10mM/1mL | 613,00 | Add | |
| HY-10319-10MG | 10 mg | 723,00 | Add | |
| HY-10319-25MG | 25 mg | 1'432,00 | Add | |
| HY-10319-50MG | 50 mg | 2'281,00 | Add | |
| HY-10319-100MG | 100 mg | 3'637,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
BAY-549 (Azaindole 1) is an orally active and ATP-competitive ROCK inhibitor with IC50s of 0.6 and 1.1 nM for human ROCK-1 and ROCK-2, respectively[1].
| Category | Inhibitor |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cardiovascular Disease, Cell Cycle/DNA Damage,Cytoskeleton,Stem Cell/Wnt,TGF-beta/Smad |
| Format | Solubility: DMSO : 33.33 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 99.46% |
| Molecular Formula | C18H13ClF2N6O |
| Molecular Weight | 402.79 |
| CAS-Number | 867017-68-3 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
